The Current Ratio as of November 2024 (TTM) for NovaBay Pharmaceuticals, Inc. (NBY) is 1.15

According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.15. This represents a change of 5.38% compared to the average of 1.09 of the last 4 quarters.

NovaBay Pharmaceuticals, Inc. (NBY) Historical Current Ratio (quarterly & annually)

How has NBY Current Ratio performed in the past?

The mean historical Current Ratio of NovaBay Pharmaceuticals, Inc. over the last ten years is 2.53. The current 1.15 Current Ratio has changed 4.44% with respect to the historical average. Over the past ten years (40 quarters), NBY's Current Ratio was at its highest in in the June 2021 quarter at 5.35. The Current Ratio was at its lowest in in the June 2024 quarter at 0.62.

NovaBay Pharmaceuticals, Inc. (NBY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovaBay Pharmaceuticals, Inc. (NBY) Average Current Ratio

How has NBY Current Ratio performed in the past?

The current Current Ratio of NovaBay Pharmaceuticals, Inc. (NBY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NovaBay Pharmaceuticals, Inc. (NBY) Current Ratio vs. Peers

How is NBY’s Current Ratio compared to its peers?

NovaBay Pharmaceuticals, Inc.’s Current Ratio is less than Immix Biopharma, Inc. (3.47), less than CNS Pharmaceuticals, Inc. (1.82), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), greater than ZyVersa Therapeutics, Inc. (0.03), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than Zura Bio Limited (10.36), less than Altamira Therapeutics Ltd. (1.38), less than Enveric Biosciences, Inc. (5.17), less than Palisade Bio, Inc. (3.31), less than Phio Pharmaceuticals Corp. (6.38),

Build a custom stock screener for NovaBay Pharmaceuticals, Inc. (NBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBay Pharmaceuticals, Inc. (NBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.